Information;Judgment — ECLI:EU:T:2021:541
Date: 2021-09-08
Language of the case: English
Court formation: Second Chamber
Subject matter: Trade marks;Intellectual, industrial and commercial property
Procedure: Action for annulment - unfounded

Judgment of the General Court of 8 September 2021 – Cara Therapeutics v EUIPO – Gebro Holding (KORSUVA) (Case T-584/20) 1 (EU trade mark – Opposition proceedings – Application for the EU word mark KORSUVA – Earlier national word mark AROSUVA – Relative ground for refusal – Likelihood of confusion – Article 8(1)(b) of Regulation (EU) 2017/1001) Language of the case: English Parties Applicant: Cara Therapeutics, Inc. (Wilmington, Delaware, United States) (represented by: J. Day, Solicitor, and by T. de Haan, lawyer) Defendant: European Union Intellectual Property Office (represented by: J. Ivanauskas and V. Ruzek, acting as Agents) Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Gebro Holding GmbH (Fieberbrunn, Austria) (represented by: M. Konzett, lawyer) Re: Action brought against the decision of the Fourth Board of Appeal of EUIPO of 3 July 2020 (Case R 2450/2019-4), relating to opposition proceedings between Gebro Holding and Cara Therapeutics. Operative part of the judgment The Court: Dismisses the action; Orders Cara Therapeutic, Inc. to pay the costs. ____________ 1 OJ C 390, 16.11.2020.